Purchase Order 75N98026P01708
Award Date 9/18/26
Potential Completion Date 3/31/27
Potential Value $109K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lincoln, NE 68504, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for a LICOR Odyssey CLX imaging system with a ceiling value of $50,254.16 on September 17, 2018. Performance takes place in Lincoln, Nebraska. The order is firm fixed price with no small business set-aside. Ultimate completion is scheduled for October 17, 2018. The procurement originated from a solicitation posted August 27, 2018 with a due date of September 5, 2018.</p>
- The National Cancer Institute issued a purchase order to Li-Cor Biotech, LLC on June 12, 2026, for one Odyssey M Chemi/Fluor Imaging Bundle Standard imaging system, valued at $92,376.00 and due for completion by July 12, 2026. The acquisition was sole-source, non-competitive under FAR Parts 12 and 13, justified on a brand-name basis. Place of performance is Lincoln, Nebraska. The system includes four solid-state laser diodes (488, 520, 685, and 785 nm wavelengths), sCMOS fluorescence...
- The National Cancer Institute issued a purchase order to Li-Cor, Inc. on June 12, 2026, for one LI-COR Biotech Odyssey M Chemi/Fluor Imaging Bundle Standard system valued at $92,376.00, with completion expected by July 12, 2026. The order is firm fixed price and carries no set-aside designation. Place of performance is Lincoln, Nebraska (the vendor's manufacturing location); delivery and installation occur at the National Cancer Institute's Laboratory of Human Carcinogenesis in Bethesda,...
- <p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for $3,825.00 on August 11, 2017. The order covers one-year support service for a 9140-80 Odyssey Classic/CLX-0846 instrument, with performance in Lincoln, Nebraska. Work includes service per the attached statement of work and invoicing instructions, concluding August 10, 2018.</p>
- The National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a firm fixed price purchase order to Li-Cor, Inc. (doing business as Li-Cor Bio Sciences) for the procurement of one (1) Li-COR Odyssey M Imaging System for $80,153.10. The award has a completion date of February 9, 2023 and was made through a solicitation with no set-aside designation. Li-Cor, Inc. is a manufacturer of scientific instruments and analysis software that has received prior federal contract and grant...
- <p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for a maintenance agreement valued at $5,250.00, effective February 14, 2018, with completion scheduled for February 21, 2019. Performance takes place in Lincoln, Nebraska. The order is a firm fixed-price maintenance agreement with no set-aside designation. Li-Cor, Inc., doing business as Li-Cor Bio Sciences, is a for-profit manufacturer of scientific instruments and analysis software.</p>
- <p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for $3,825.00 on February 21, 2018, with a completion date of March 26, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is for firm fixed-price scientific instruments and equipment, consistent with Li-Cor's specialization in manufacturing high-precision environmental monitoring and analytical instrumentation for federal research agencies.</p>
- Li-Cor, Inc., doing business as Li-Cor Bio Sciences, has been awarded a $33,240 purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver an ODYSSEY XF data integrity bundle imaging system. Performance will occur in Lincoln, Nebraska over a five-week period concluding in mid-February 2024. The firm fixed price contract supports the NIH's research efforts to advance understanding of diseases such...
- <p>The National Cancer Institute issued a $33,983.66 delivery order to Li-Cor, Inc. on May 11, 2018, under the GSA Schedule for Scientific Equipment and Services (FSS-66).</p> <p>Li-Cor, Inc., doing business as Li-Cor Bio Sciences, is a for-profit manufacturer of scientific instruments and analysis software. Place of performance is San Diego, CA 92121. The order was priced firm fixed price with no set-aside applied. Ultimate completion date is May 10, 2019.</p>
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Li-Cor, Inc. (doing business as Li-Cor BioSciences) for an Odyssey M Bundle Imaging System. The system will be used to perform investigations related to the molecular biology of viruses, virus-host cell interactions, viral pathogenesis, and host defense mechanisms. The potential value of the award is...